Post Profile






Roche And Lonza Enter Into MycoTOOL Distribution Agreement For Rapid Mycoplasma Testing Solutions

Roche (SIX: RO, ROG; OTCQX: RHHBY) and Lonza announced today that they have entered into a co-exclusive distribution agreement for the commercialization of Roche's MycoTOOL mycoplasma PCR assays. MycoTOOL detection kits are now available through Lonza for final release testing of pharmaceutical products, upon validation. Additionally, Lonza offers contract testing services using the MycoTOOL test.
read more

share

Related Posts


Pivotal Study Validates Roche's CobasĀ® HPV Test With HPV-16 And 18 Genotyping For Identifying Women At Highest Risk For Cervical Cancer

Health : Medical News Today

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that a study published online in the American Journal of Clinical Pathology demonstrated the ability of the cobas HPV Test to individually detect HPV-16 and HPV-18, two of the highest ris...

Roche Diagnostics Supports European Union's DETECTIVE Project To Reduce Animal Testing

Health : Medical News Today

The xCELLigence RTCA System of Roche (SIX: RO, ROG; OTCQX: RHHBY) is being used in the European Union's DETECTIVE ("Detection of endpoints and biomarkers for repeated dose toxicity using in vitro systems") Project, a joint study fun...

Roche Receives FDA Approval For Acute Hepatitis B Test

Health : Medical News Today

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) granted Premarket Approval (PMA) for its IgM antibody to hepatitis B core antigen (Anti-HBc IgM) assay for use on the cobas e 601 an...

Roche Applied Science And TIB Molbiol Offer Assay Solution For Rapid EHEC Identification

Health : Medical News Today

With the recent outbreak in Europe of Enterohaemorrhagic Escherichia coli (EHEC), Roche Applied Science (SIX: RO, ROG; OTCQX: RHHBY) and TIB Molbiol are providing scientists with complementary technologies that can be used for the r...

Roche And Merck Collaborate To Develop Diagnostic Tests For Merck's Investigational Cancer Therapies

Health : Medical News Today

Merck (NYSE:MRK), known outside the United States and Canada as MSD, and Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that they have entered into a collaboration focused on the application and development of diagnostic assays ...

Comments


Copyright © 2016 Regator, LLC